{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:52:52Z","timestamp":1781045572222,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Secretory breast carcinoma is an uncommon subset of breast cancer that usually has a favorable outcome. Although initially described in children, it also occurs in adults where it may metastasize, possibly resulting in death. To date, only 20 cases of secretory breast carcinoma with distant metastases have been described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 42-year-old female presented with liver metastasis after modified radical mastectomy of the left breast in 2008 at 34 years of age. The liver metastasis was morphologically similar to the primary tumor. Pan-TRK and Fluorescence in situ hybridization showed a rearrangement in the ETV6 gene. She subsequently underwent adjuvant chemotherapy with a fatal outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although secretory breast carcinoma is usually associated with favorable outcomes, our study and reviews provide a novel insight into the genetic spectrum and treatment of secretory breast carcinoma showing reduced expression of hormone receptors, abnormal genomic profiles, and possible poor prognosis. Targeted therapy may curb clinically aggressive cases. Additional molecular investigations are needed to determine the links between specific mutations and poor prognosis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13000-021-01156-6","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:35:49Z","timestamp":1633901749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review"],"prefix":"10.1186","volume":"16","author":[{"given":"Jing","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0670-7141","authenticated-orcid":false,"given":"Yan-feng","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-ming","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,10]]},"reference":[{"issue":"2","key":"1156_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/his.13879","volume":"75","author":"RS Hoda","year":"2019","unstructured":"Hoda RS, et al. Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential. Histopathology. 2019;75(2):213\u201324.","journal-title":"Histopathology"},{"issue":"7","key":"1156_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jso.24241","volume":"113","author":"JD Jacob","year":"2016","unstructured":"Jacob JD, et al. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base. J Surg Oncol. 2016;113(7):721\u20135.","journal-title":"J Surg Oncol"},{"issue":"1","key":"1156_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.20892\/j.issn.2095-3941.2018.0035","volume":"16","author":"L Li","year":"2019","unstructured":"Li L, et al. Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma. Cancer Biol Med. 2019;16(1):139\u201346.","journal-title":"Cancer Biol Med"},{"key":"1156_CR4","doi-asserted-by":"crossref","unstructured":"Tognon C, Huntsman SRK D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Poul HB, Sorensen. Expression of the ETV6\u2013NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2:367\u201376.","DOI":"10.1016\/S1535-6108(02)00180-0"},{"issue":"2","key":"1156_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/modpathol.2008.184","volume":"22","author":"M Lae","year":"2009","unstructured":"Lae M, et al. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Mod Pathol. 2009;22(2):291\u20138.","journal-title":"Mod Pathol"},{"key":"1156_CR6","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1023\/A:1008387800525","volume":"11","author":"H Herz","year":"2000","unstructured":"Herz H, Goldstein BCD. Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: case report and review of the literature. Ann Oncol. 2000;11:1343\u20137.","journal-title":"Ann Oncol"},{"issue":"5","key":"1156_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0242-6498(04)93999-5","volume":"24","author":"G Woto-Gaye","year":"2004","unstructured":"Woto-Gaye G, et al. Secretory breast carcinoma in a man. A case report with rapid evolution unfavorable. Ann Pathol. 2004;24(5):432\u20135.","journal-title":"Ann Pathol"},{"key":"1156_CR8","doi-asserted-by":"crossref","unstructured":"Ozguroglu M, et al. Secretory carcinoma of the breast. Case report and review of the literature. Oncology. 2005;68(2\u20133):263\u20138.","DOI":"10.1159\/000086782"},{"key":"1156_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5858\/2006-130-e50-ALFBM","volume":"130","author":"PACTAE Resetkova","year":"2006","unstructured":"Resetkova PACTAE. A large, fungating breast mass. Arch Pathol Lab Med. 2006;130:50\u20132.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"1156_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/tbj.12041","volume":"18","author":"M Wong","year":"2012","unstructured":"Wong M, et al. ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma. Breast J. 2012;18(6):604\u20136.","journal-title":"Breast J"},{"key":"1156_CR11","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1097\/PAS.0000000000000487","volume":"39","author":"D Marie","year":"2015","unstructured":"Marie D, Castillo FdrC, Arnould L, Croce S, Ribeiro Agnes, Perot Ga\u00eblle, Hostein Isabelle, Geha Sameh, Bozon Catherine, Garnier Agnes, Lae Marick, Vincent-Salomon Anne, MacGrogan Ga\u00ebtan. A histopathologic and genomic spectrum characterized by a joint specific ETV6-NTRK3 gene fusion. Am J Surg Pathol. 2015;39:1458\u201367.","journal-title":"Am J Surg Pathol"},{"key":"1156_CR12","doi-asserted-by":"crossref","unstructured":"Neerav Shukla SSR, Mollah O, Baki, et al. Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma. JCO Precis Oncol; 2017;2017:PO.17.00034.","DOI":"10.1200\/PO.17.00034"},{"issue":"6","key":"1156_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/tbj.13126","volume":"24","author":"JW Garlick","year":"2018","unstructured":"Garlick JW, et al. Secretory breast carcinoma in an 8-year-old girl: a case report and literature review. Breast J. 2018;24(6):1055\u201361.","journal-title":"Breast J"},{"issue":"3","key":"1156_CR14","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1016\/j.clbc.2017.11.017","volume":"18","author":"Y Landman","year":"2018","unstructured":"Landman Y, et al. Rapid response to larotrectinib (LOXO-101) in an adult chemotherapy-naive patients with advanced triple-negative secretory breast cancer expressing ETV6-NTRK3 fusion. Clin Breast Cancer. 2018;18(3):e267-70.","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"1156_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.breast.2012.02.013","volume":"21","author":"DP Horowitz","year":"2012","unstructured":"Horowitz DP, et al. Secretory carcinoma of the breast: results from the survival, epidemiology and end results database. Breast. 2012;21(3):350\u20133.","journal-title":"Breast"},{"key":"1156_CR16","first-page":"3322","volume":"8","author":"LJ Jinhua Ding","year":"2015","unstructured":"Jinhua Ding LJ, Gan Y, Wu W. A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis. Int J Clin Exp Pathol. 2015;8:3322\u20137.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"1156_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/modpathol.3800570","volume":"19","author":"BB Bryan","year":"2006","unstructured":"Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol. 2006;19(5):617\u201321.","journal-title":"Mod Pathol"},{"issue":"4","key":"1156_CR18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/his.12172","volume":"63","author":"T Osako","year":"2013","unstructured":"Osako T, et al. Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis. Histopathology. 2013;63(4):509\u201319.","journal-title":"Histopathology"},{"issue":"4","key":"1156_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/modpathol.2011.190","volume":"25","author":"D Li","year":"2012","unstructured":"Li D, et al. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature. Mod Pathol. 2012;25(4):567\u201375.","journal-title":"Mod Pathol"},{"issue":"12","key":"1156_CR20","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.5858\/arpa.2010-0351-RS","volume":"135","author":"P Vasudev","year":"2011","unstructured":"Vasudev P, Onuma K. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Arch Pathol Lab Med. 2011;135(12):1606\u201310.","journal-title":"Arch Pathol Lab Med"},{"key":"1156_CR21","doi-asserted-by":"crossref","unstructured":"Tavassoli FA, Norris HJ. Secretory carcinoma of the breast.Cancer. 1980;45:2404\u201313.","DOI":"10.1002\/1097-0142(19800501)45:9<2404::AID-CNCR2820450928>3.0.CO;2-8"},{"key":"1156_CR22","unstructured":"Tokunaga M, Wakimoto J, Muramoto Y, et al. Juvenile secretory carcinoma and juvenile papillomatosis. Jpn J Clin Oncol. 1985;15:457\u201365."},{"key":"1156_CR23","doi-asserted-by":"crossref","unstructured":"Nguyen GK, Neifer R. Aspiration biopsy cytology of secretory carcinoma of the breast. Diagn Cytopathol. 1987;3:234\u20137.","DOI":"10.1002\/dc.2840030312"},{"key":"1156_CR24","doi-asserted-by":"crossref","unstructured":"Krausz T, Jenkins D, Grontoft O, Pollock DJ, Azzopardi JG. Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology. 1989;14:25\u201336.","DOI":"10.1111\/j.1365-2559.1989.tb02111.x"},{"key":"1156_CR25","doi-asserted-by":"crossref","unstructured":"Krohn M, Trams G, Brandt G. Secretory breast cancer. Secretory breast cancer. A special morphologic entity, especially in children and young females. Geburtshilfe Frauenheilkd. 1989;49:299\u2013301.","DOI":"10.1055\/s-2008-1035759"},{"key":"1156_CR26","doi-asserted-by":"crossref","unstructured":"Arce C, Cortes-Padilla D, Huntsman DG, et al. Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature. World J Surg Oncol. 2005;3:35.","DOI":"10.1186\/1477-7819-3-35"},{"key":"1156_CR27","doi-asserted-by":"crossref","unstructured":"Anderson P, Albarracin CT, Resetkova E. A large, fungating breast mass. Secretory carcinoma with apocrine differentiation. Arch Pathol Lab Med. 2006;130:e50\u20132.","DOI":"10.5858\/2006-130-e50-ALFBM"},{"key":"1156_CR28","doi-asserted-by":"crossref","unstructured":"Landman Y, Ilouze M, Wein S, et al. Rapid response to larotrectinib (LOXO-101) in an adult chemotherapynaive patients with advanced triple-negative secretory breast cancer expressing ETV6\u2013NTRK3 fusion. Clin Breast Cancer. 2018;18:e267\u2013720.","DOI":"10.1016\/j.clbc.2017.11.017"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-021-01156-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T20:05:53Z","timestamp":1699646753000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-021-01156-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1186\/s13000-021-01156-6","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,10]]},"assertion":[{"value":"10 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Human Research Ethics Board of Shanxi Provincial Cancer Hospital (Approval number: 2019075).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}